Trial Profile
A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 24 Mar 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Mar 2015 New trial record